GlassScriptPhysician profile
Lisa Lee Standlee
NPI 1831728690
$2,778.05
in general payments reported to CMS, 2019-2025
30 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $887 · 2023: $634 · 2024: $617 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $340.78 | 2022-2024 | Korlym |
| Angiodynamics, INC. | $275.05 | 2023 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Organogenesis INC. | $196.57 | 2022-2023 | Puraply |
| Nevro Corp. | $167.63 | 2022-2024 | Senza |
| Kerecis Limited | $155.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $126.88 | 2022-2023 | Kimyrsa |
| Revance Therapeutics, INC. | $125.17 | 2025 | Daxi |
| Abbvie INC. | $124.40 | 2024 | |
| Idorsia Pharmaceuticals US INC | $124.04 | 2023 | Quviviq |
| Dexcom, INC. | $121.52 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Medtronic, INC. | $117.09 | 2022 | |
| Amgen INC. | $102.60 | 2022 | |
| Smith+Nephew, INC. | $100.25 | 2021-2024 | Collagenase Santyl, Regranex |
| Esperion Therapeutics, INC. | $83.87 | 2021 | |
| Inspire Medical Systems, INC. | $80.49 | 2025 | Inspire |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $79.05 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.66 | 2025 | |
| Becton, Dickinson and Company | $60.90 | 2024 | Venovo |
| Tactile Systems Technology INC | $49.00 | 2022 | |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Boston Scientific Corporation | $44.62 | 2024 | |
| Hydrofera LLC | $38.88 | 2022 | |
| Getinge USA Sales, LLC | $27.29 | 2021 | |
| Veryan Medical Incorporated | $22.56 | 2021 | |
| Convatec INC. | $20.82 | 2022 | |
| Kci USA, INC. | $18.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.26 | 2022 | |
| Cook Medical LLC | $15.89 | 2022 | |
| Urgo Medical North America, LLC | $14.91 | 2024 | Urgoclean Ag |
| Cardiovascular Systems INC. | $8.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Standlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.